Erratum: Wip1 Controls Global Heterochromatin Silencing via ATM/BRCA1-Dependent DNA Methylation (Cancer Cell (2013) 24(4) (528–541) (S1535610813003681) (10.1016/j.ccr.2013.08.022));Wip1 Controls Global Heterochromatin Silencing via ATM/BRCA1-Dependent DNA Methylation

Cancer Cell

Volumn 24, Issue 4, 2013, Pages 528-541

  Filipponi, Doria ^a   Muller, Julius ^a   Emelyanov, Alexander ^a   Bulavin, DmitryV ^a  

^a INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; BRCA1 PROTEIN; CYSTEINE; DNA; HETEROCHROMATIN PROTEIN 1; MEMBRANE PROTEIN; REPETITIVE DNA; THREONINE; UNCLASSIFIED DRUG; WIP1 PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; BREAST CANCER; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA DAMAGE; DNA METHYLATION; DNA SEQUENCE; EPIGENETICS; GENE MUTATION; GENE SILENCING; GENOME; HETEROCHROMATIN; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIMARY TUMOR; PRIORITY JOURNAL; SPERMATOGENESIS; SUBSTITUTION REACTION; TRANSCRIPTION REGULATION;

EID: 84885340349     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccell.2016.07.016     Document Type: Erratum

References (48)

1. Baarends W.M., Wassenaar E., van der Laan R., Hoogerbrugge J., Sleddens-Linkels E., Hoeijmakers J.H., de Boer P., Grootegoed J.A. Silencing of unpaired chromatin and histone H2A ubiquitination in mammalian meiosis. Mol. Cell. Biol. 2005, 25:1041-1053.
2. Baylin S., Bestor T.H. Altered methylation patterns in cancer cell genomes: cause or consequence?. Cancer Cell 2002, 1:299-305.
3. Bird A., Macleod D. Reading the DNA methylation signal. Cold Spring Harb. Symp. Quant. Biol. 2004, 69:113-118.
4. Bulavin D.V., Demidov O.N., Saito S., Kauraniemi P., Phillips C., Amundson S.A., Ambrosino C., Sauter G., Nebreda A.R., Anderson C.W., et al. Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity. Nat. Genet. 2002, 31:210-215.
5. Bulavin D.V., Phillips C., Nannenga B., Timofeev O., Donehower L.A., Anderson C.W., Appella E., Fornace A.J. Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway. Nat. Genet. 2004, 36:343-350.
6. Burma S., Chen B.P., Murphy M., Kurimasa A., Chen D.J. ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J.Biol. Chem. 2001, 276:42462-42467.
7. Burns M.B., Lackey L., Carpenter M.A., Rathore A., Land A.M., Leonard B., Refsland E.W., Kotandeniya D., Tretyakova N., Nikas J.B., et al. APOBEC3B is an enzymatic source of mutation in breast cancer. Nature 2013, 494:366-370.
8. Cerami E., Gao J., Dogrusoz U., Gross B.E., Sumer S.O., Aksoy B.A., Jacobsen A., Byrne C.J., Heuer M.L., Larsson E., et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012, 2:401-404.
9. Choi J., Nannenga B., Demidov O.N., Bulavin D.V., Cooney A., Brayton C., Zhang Y., Mbawuike I.N., Bradley A., Appella E., Donehower L.A. Mice deficient for the wild-type p53-induced phosphatase gene (Wip1) exhibit defects in reproductive organs, immune function, and cell cycle control. Mol. Cell. Biol. 2002, 22:1094-1105.
10. Choi J.D., Park M.A., Lee J.S. Suppression and recovery of BRCA1-mediated transcription by HP1γ via modulation of promoter occupancy. Nucleic Acids Res. 2012, 40:11321-11338.
11. Chowdhury M., Forouhi O., Dayal S., McCloskey N., Gould H.J., Felsenfeld G., Fear D.J. Analysis of intergenic transcription and histone modification across the human immunoglobulin heavy-chain locus. Proc. Natl. Acad. Sci. USA 2008, 105:15872-15877.
12. Cortez D., Wang Y., Qin J., Elledge S.J. Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks. Science 1999, 286:1162-1166.
13. Coufal N.G., Garcia-Perez J.L., Peng G.E., Marchetto M.C., Muotri A.R., Mu Y., Carson C.T., Macia A., Moran J.V., Gage F.H. Ataxia telangiectasia mutated (ATM) modulates long interspersed element-1 (L1) retrotransposition in human neural stem cells. Proc. Natl. Acad. Sci. USA 2011, 108:20382-20387.
14. Demidov O.N., Timofeev O., Lwin H.N., Kek C., Appella E., Bulavin D.V. Wip1 phosphatase regulates p53-dependent apoptosis of stem cells and tumorigenesis in the mouse intestine. Cell Stem Cell 2007, 1:180-190.
15. Fernandez-Capetillo O., Mahadevaiah S.K., Celeste A., Romanienko P.J., Camerini-Otero R.D., Bonner W.M., Manova K., Burgoyne P., Nussenzweig A. H2AX is required for chromatin remodeling and inactivation of sex chromosomes in male mouse meiosis. Dev. Cell 2003, 4:497-508.
16. Goll M.G., Bestor T.H. Eukaryotic cytosine methyltransferases. Annu. Rev. Biochem. 2005, 74:481-514.
17. Goodier J.L., Kazazian H.H. Retrotransposons revisited: the restraint and rehabilitation of parasites. Cell 2008, 135:23-35.
18. Gopalakrishnan S., Van Emburgh B.O., Robertson K.D. DNA methylation in development and human disease. Mutat. Res. 2008, 647:30-38.
19. Guibert S., Forné T., Weber M. Global profiling of DNA methylation erasure in mouse primordial germ cells. Genome Res. 2012, 22:633-641.
20. Haiman C.A., Chen G.K., Vachon C.M., Canzian F., Dunning A., Millikan R.C., Wang X., Ademuyiwa F., Ahmed S., Ambrosone C.B., et al. A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat. Genet. 2011, 43:1210-1214. Gene Environment Interaction and Breast Cancer in Germany (GENICA) Consortium.
21. Hancks D.C., Kazazian H.H. Active human retrotransposons: variation and disease. Curr. Opin. Genet. Dev. 2012, 22:191-203.
22. Hsiung D.T., Marsit C.J., Houseman E.A., Eddy K., Furniss C.S., McClean M.D., Kelsey K.T. Global DNA methylation level in whole blood as a biomarker in head and neck squamous cell carcinoma. Cancer Epidemiol. Biomarkers Prev. 2007, 16:108-114.
23. Iskow R.C., McCabe M.T., Mills R.E., Torene S., Pittard W.S., Neuwald A.F., Van Meir E.G., Vertino P.M., Devine S.E. Natural mutagenesis of human genomes by endogenous retrotransposons. Cell 2010, 141:1253-1261.
24. Jeppesen P., Mitchell A., Turner B., Perry P. Antibodies to defined histone epitopes reveal variations in chromatin conformation and underacetylation of centric heterochromatin in human metaphase chromosomes. Chromosoma 1992, 101:322-332.
25. Kimmins S., Sassone-Corsi P. Chromatin remodelling and epigenetic features of germ cells. Nature 2005, 434:583-589.
26. Koboldt D.C. Comprehensive molecular portraits of human breast tumours. Nature 2012, 490:61-70. Cancer Genome Atlas Network.
27. Kruhlak M.J., Celeste A., Dellaire G., Fernandez-Capetillo O., Müller W.G., McNally J.G., Bazett-Jones D.P., Nussenzweig A. Changes in chromatin structure and mobility in living cells at sites of DNA double-strand breaks. J.Cell Biol. 2006, 172:823-834.
28. Kruhlak M., Crouch E.E., Orlov M., Montaño C., Gorski S.A., Nussenzweig A., Misteli T., Phair R.D., Casellas R. The ATM repair pathway inhibits RNA polymerase I transcription in response to chromosome breaks. Nature 2007, 447:730-734.
29. Lachner M., O'Carroll D., Rea S., Mechtler K., Jenuwein T. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 2001, 410:116-120.
30. Lavin M.F. Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer. Nat. Rev. Mol. Cell Biol. 2008, 9:759-769.
31. Le Guezennec X., Brichkina A., Huang Y.F., Kostromina E., Han W., Bulavin D.V. Wip1-dependent regulation of autophagy, obesity, and atherosclerosis. Cell Metab. 2012, 16:68-80.
32. Lehnertz B., Ueda Y., Derijck A.A., Braunschweig U., Perez-Burgos L., Kubicek S., Chen T., Li E., Jenuwein T., Peters A.H. Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin. Curr. Biol. 2003, 13:1192-1200.
33. Li E. Chromatin modification and epigenetic reprogramming in mammalian development. Nat. Rev. Genet. 2002, 3:662-673.
34. Li J., Yang Y., Peng Y., Austin R.J., van Eyndhoven W.G., Nguyen K.C., Gabriele T., McCurrach M.E., Marks J.R., Hoey T., et al. Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23. Nat. Genet. 2002, 31:133-134.
35. Lu X., Bocangel D., Nannenga B., Yamaguchi H., Appella E., Donehower L.A. The p53-induced oncogenic phosphatase PPM1D interacts with uracil DNA glycosylase and suppresses base excision repair. Mol. Cell 2004, 15:621-634.
36. Maison C., Almouzni G. HP1 and the dynamics of heterochromatin maintenance. Nat. Rev. Mol. Cell Biol. 2004, 5:296-304.
37. Morandi L., Franceschi E., de Biase D., Marucci G., Tosoni A., Ermani M., Pession A., Tallini G., Brandes A. Promoter methylation analysis of O6-methylguanine-DNA methyltransferase in glioblastoma: detection by locked nucleic acid based quantitative PCR using an imprinted gene (SNURF) as a reference. BMC Cancer 2010, 10:48.
38. Nabel C.S., Jia H., Ye Y., Shen L., Goldschmidt H.L., Stivers J.T., Zhang Y., Kohli R.M. AID/APOBEC deaminases disfavor modified cytosines implicated in DNA demethylation. Nat. Chem. Biol. 2012, 8:751-758.
39. Peters A.H., O'Carroll D., Scherthan H., Mechtler K., Sauer S., Schöfer C., Weipoltshammer K., Pagani M., Lachner M., Kohlmaier A., et al. Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell 2001, 107:323-337.
40. Shakya R., Reid L.J., Reczek C.R., Cole F., Egli D., Lin C.S., deRooij D.G., Hirsch S., Ravi K., Hicks J.B., et al. BRCA1 tumor suppression depends on BRCT phosphoprotein binding, but not its E3 ligase activity. Science 2011, 334:525-528.
41. Shanbhag N.M., Rafalska-Metcalf I.U., Balane-Bolivar C., Janicki S.M., Greenberg R.A. ATM-dependent chromatin changes silence transcription in cis to DNA double-strand breaks. Cell 2010, 141:970-981.
42. Shreeram S., Demidov O.N., Hee W.K., Yamaguchi H., Onishi N., Kek C., Timofeev O.N., Dudgeon C., Fornace A.J., Anderson C.W., et al. Wip1 phosphatase modulates ATM-dependent signaling pathways. Mol. Cell 2006, 23:757-764.
43. Shreeram S., Hee W.K., Demidov O.N., Kek C., Yamaguchi H., Fornace A.J., Anderson C.W., Appella E., Bulavin D.V. Regulation of ATM/p53-dependent suppression of myc-induced lymphomas by Wip1 phosphatase. J.Exp. Med. 2006, 203:2793-2799.
44. Shukla R., Upton K.R., Muñoz-Lopez M., Gerhardt D.J., Fisher M.E., Nguyen T., Brennan P.M., Baillie J.K., Collino A., Ghisletti S., et al. Endogenous retrotransposition activates oncogenic pathways in hepatocellular carcinoma. Cell 2013, 153:101-111.
45. Smith Z.D., Meissner A. DNA methylation: roles in mammalian development. Nat. Rev. Genet. 2013, 14:204-220.
46. Ting D.T., Lipson D., Paul S., Brannigan B.W., Akhavanfard S., Coffman E.J., Contino G., Deshpande V., Iafrate A.J., Letovsky S., et al. Aberrant overexpression of satellite repeats in pancreatic and other epithelial cancers. Science 2011, 331:593-596.
47. Toraño E.G., Petrus S., Fernandez A.F., Fraga M.F. Global DNA hypomethylation in cancer: review of validated methods and clinical significance. Clin. Chem. Lab. Med. 2012, 50:1733-1742.
48. Zhu Q., Pao G.M., Huynh A.M., Suh H., Tonnu N., Nederlof P.M., Gage F.H., Verma I.M. BRCA1 tumour suppression occurs via heterochromatin-mediated silencing. Nature 2011, 477:179-184.